METHYLGUANIDINE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C2H7N3
Molecular Weight	73.0971
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

SMILES

CNC(N)=N

InChI

InChIKey=CHJJGSNFBQVOTG-UHFFFAOYSA-N

InChI=1S/C2H7N3/c1-5-2(3)4/h1H3,(H4,3,4,5)

HIDE SMILES / InChI

Approval Year

PubMed

Show entries

Title	Date	PubMed
Uremic intoxication.	1975	1093053
Automatic system for the assay of guanidino compounds to assess uremic status.	2000 Sep	10993196
Endogenous guanidino compounds as uremic neurotoxins.	2001 Feb	11168988
Increased retinal endothelial cell monolayer permeability induced by the diabetic milieu: role of advanced non-enzymatic glycation and polyol pathway activation.	2001 Nov-Dec	11757081
In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection.	2004 Jun	15149331

Showing 1 to 5 of 20 entries

Previous1 2 3 4Next

Patents

Show entries

Name

Type

Language

METHYLGUANIDINE

Systematic Name

English

METHYLGUANIDINE [MI]

Preferred Name

English

N-METHYLGUANIDINE

Systematic Name

English

Showing 1 to 3 of 3 entries

Previous1Next

Show entries

Code System

Code

Type

Description

CAS

471-29-4

PRIMARY

CHEBI

16628

PRIMARY

MERCK INDEX

m7425

PRIMARY

Merck Index

PUBCHEM

10111

PRIMARY

FDA UNII

5L0H5Q9VAG

PRIMARY

Showing 1 to 5 of 9 entries

Previous1 2Next

SUBSTANCE RECORD


					5L0H5Q9VAG

METHYLGUANIDINE